Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pancreatitis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 101 articles:
HTML format



Single Articles


    January 2022
  1. KRUGER D, Lahoud N, Yako YY, Devar J, et al
    Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease.
    PLoS One. 2022;17:e0262439.
    PubMed     Abstract available


  2. ALVES FAV, Oliveira LLS, Salomao NG, Provance DW Jr, et al
    Cytokines and inflammatory mediators: Markers involved in interstitial damage to the pancreas in two dengue fever cases associated with acute pancreatitis.
    PLoS One. 2022;17:e0262785.
    PubMed     Abstract available


  3. KARKI B, Thapa S, Khadka D, Karki S, et al
    Intravenous Ringers lactate versus normal saline for predominantly mild acute pancreatitis in a Nepalese Tertiary Hospital.
    PLoS One. 2022;17:e0263221.
    PubMed     Abstract available



  4. Retraction: MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2022;17:e0263037.
    PubMed    


  5. MUHAMMADZAI J, Haider K, Moser M, Chalchal H, et al
    Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort study.
    PLoS One. 2022;17:e0263250.
    PubMed     Abstract available


  6. RYDENFELT K, Strand-Amundsen R, Horneland R, Hodnebo S, et al
    Microdialysis and CO2 sensors detect pancreatic ischemia in a porcine model.
    PLoS One. 2022;17:e0262848.
    PubMed     Abstract available


  7. LUIKEN I, Eisenmann S, Garbe J, Sternby H, et al
    Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severity.
    PLoS One. 2022;17:e0263739.
    PubMed     Abstract available


  8. VITALE DS, Lahni P, Hornung L, Thompson T, et al
    Matrix metalloproteinases and their inhibitors in pediatric severe acute pancreatitis.
    PLoS One. 2022;17:e0261708.
    PubMed     Abstract available


  9. YAMAI T, Ikezawa K, Hiraga E, Kawamoto Y, et al
    Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
    PLoS One. 2022;17:e0264653.
    PubMed     Abstract available


  10. TANIUCHI K, Ueno M, Yokose T, Sakaguchi M, et al
    Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients.
    PLoS One. 2022;17:e0265172.
    PubMed     Abstract available


  11. GARDNER KP, Tsai S, Aldakkak M, Gironda S, et al
    CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer.
    PLoS One. 2022;17:e0264763.
    PubMed     Abstract available


  12. STHIJNS MMJPE, Rademakers T, Oosterveer J, Geuens T, et al
    The response of three-dimensional pancreatic alpha and beta cell co-cultures to oxidative stress.
    PLoS One. 2022;17:e0257578.
    PubMed     Abstract available


  13. DONG Y, Ruano SH, Mishra A, Pennington KA, et al
    Adrenomedullin and its receptors are expressed in mouse pancreatic beta-cells and suppresses insulin synthesis and secretion.
    PLoS One. 2022;17:e0265890.
    PubMed     Abstract available


  14. ARNOLETTI JP, Reza J, Rosales A, Monreal A, et al
    Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
    PLoS One. 2022;17:e0265725.
    PubMed     Abstract available


  15. MURATA Y, Ogura T, Hayasaki A, Gyoten K, et al
    Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy.
    PLoS One. 2022;17:e0264573.
    PubMed     Abstract available


  16. KUMSTEL S, Schreiber T, Goldstein L, Stenzel J, et al
    Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
    PLoS One. 2022;17:e0266601.
    PubMed     Abstract available


  17. UWAGAWA T, Sakamoto T, Gocho T, Shiba H, et al
    Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
    PLoS One. 2022;17:e0267623.
    PubMed     Abstract available


  18. NURMI AM, Hagstrom J, Mustonen H, Seppanen H, et al
    The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy.
    PLoS One. 2022;17:e0267792.
    PubMed     Abstract available


  19. TAKATS A, Berke G, Gede N, Nemeth BC, et al
    Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis.
    PLoS One. 2022;17:e0268859.
    PubMed     Abstract available


  20. YAMAKAWA K, Koyanagi-Aoi M, Uehara K, Masuda A, et al
    Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma.
    PLoS One. 2022;17:e0266620.
    PubMed     Abstract available


  21. THEGE FI, Cardle II, Gruber CN, Siemann MJ, et al
    Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids.
    PLoS One. 2022;17:e0267882.
    PubMed     Abstract available


  22. IWATATE Y, Yokota H, Hoshino I, Ishige F, et al
    Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer.
    PLoS One. 2022;17:e0268630.
    PubMed     Abstract available


  23. KASSAY N, Toldi V, Tozser J, Szabo A, et al
    Cigarette smoke toxin hydroquinone and misfolding pancreatic lipase variant cooperatively promote endoplasmic reticulum stress and cell death.
    PLoS One. 2022;17:e0269936.
    PubMed     Abstract available


  24. XU W, Zhang M, Liu L, Yin M, et al
    Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
    PLoS One. 2022;17:e0269612.
    PubMed     Abstract available


  25. SAKAMOTO T, Makinoya M, Sunaguchi T, Goto K, et al
    Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer.
    PLoS One. 2022;17:e0271073.
    PubMed     Abstract available


  26. HARPER MM, Lin M, Cavnar MJ, Pandalai PK, et al
    Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells.
    PLoS One. 2022;17:e0270832.
    PubMed     Abstract available


  27. DASGUPTA R, Jebasingh FK, Anoop S, Seenivasan S, et al
    Comprehensive evaluation of patterns of hypoglycemia unawareness (HUA) and glycemic variability (GV) in patients with fibrocalculous pancreatic diabetes (FCPD): A cross-sectional study from South India.
    PLoS One. 2022;17:e0270788.
    PubMed     Abstract available


  28. LI Y, Maedler K, Shu L, Haataja L, et al
    Correction: UCP-2 and UCP-3 Proteins Are Differentially Regulated in Pancreatic Beta-Cells.
    PLoS One. 2022;17:e0271783.
    PubMed     Abstract available


  29. SAITO D, Nakagawa Y, Sato T, Fukunaka A, et al
    Establishment of an enzyme-linked immunosorbent assay for mouse pancreatic polypeptide clarifies the regulatory mechanism of its secretion from pancreatic gamma cells.
    PLoS One. 2022;17:e0269958.
    PubMed     Abstract available


  30. KNOCHE SM, Brumfield GL, Goetz BT, Sliker BH, et al
    The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.
    PLoS One. 2022;17:e0273518.
    PubMed     Abstract available



  31. Retraction: Boswellic Acid Suppresses Growth and Metastasis of Human Pancreatic Tumors in an Orthotopic Nude Mouse Model through Modulation of Multiple Targets.
    PLoS One. 2022;17:e0275582.
    PubMed    


  32. LEMANSKA A, Price CA, Jeffreys N, Byford R, et al
    BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.
    PLoS One. 2022;17:e0275369.
    PubMed     Abstract available


  33. SHEBANITS K, Andersson-Assarsson JC, Larsson I, Carlsson LMS, et al
    Correction: Copy number of pancreatic polypeptide receptor gene NPY4R correlates with body mass index and waist circumference.
    PLoS One. 2022;17:e0276288.
    PubMed     Abstract available


  34. AGAWA S, Futagami S, Yamawaki H, Tsushima R, et al
    Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.
    PLoS One. 2022;17:e0275341.
    PubMed     Abstract available


  35. BERKE G, Gede N, Szadai L, Ocskay K, et al
    Bicarbonate defective CFTR variants increase risk for chronic pancreatitis: A meta-analysis.
    PLoS One. 2022;17:e0276397.
    PubMed     Abstract available


  36. MIYAMOTO R, Takahashi A, Ogasawara A, Ogura T, et al
    Three-dimensional simulation of the pancreatic parenchyma, pancreatic duct and vascular arrangement in pancreatic surgery using a deep learning algorithm.
    PLoS One. 2022;17:e0276600.
    PubMed     Abstract available


  37. OJO OA, Grant S, Amanze JC, Oni AI, et al
    Annona muricata L. peel extract inhibits carbohydrate metabolizing enzymes and reduces pancreatic beta-cells, inflammation, and apoptosis via upregulation of PI3K/AKT genes.
    PLoS One. 2022;17:e0276984.
    PubMed     Abstract available


  38. KIM YJ, Oh CM, Park SK, Jung JY, et al
    Fasting blood glucose and risk of incident pancreatic cancer.
    PLoS One. 2022;17:e0274195.
    PubMed     Abstract available


  39. GRANLUND L, Hedin A, Korsgren O, Skog O, et al
    Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
    PLoS One. 2022;17:e0276942.
    PubMed     Abstract available


    January 2021
  40. BARLASS U, Deshmukh A, Beck T, Bishehsari F, et al
    Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.
    PLoS One. 2021;16:e0244285.
    PubMed     Abstract available


  41. YOSHIOKA R, Imamura H, Ichida H, Gyoda Y, et al
    Simulation training in pancreatico-jejunostomy using an inanimate biotissue model improves the technical skills of hepatobiliary-pancreatic surgical fellows.
    PLoS One. 2021;16:e0244915.
    PubMed     Abstract available


  42. YABE SG, Fukuda S, Nishida J, Takeda F, et al
    Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
    PLoS One. 2021;16:e0245204.
    PubMed     Abstract available


  43. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    PubMed     Abstract available


  44. XIE J, Peng Y, Chen X, Li Q, et al
    LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    PLoS One. 2021;16:e0245908.
    PubMed     Abstract available


  45. HOLLENBACH M, Sonnenberg S, Sommerer I, Lorenz J, et al
    Pitfalls in AR42J-model of cerulein-induced acute pancreatitis.
    PLoS One. 2021;16:e0242706.
    PubMed     Abstract available


  46. SOGAWA K, Takano S, Ishige T, Yoshitomi H, et al
    Usefulness of the MALDI-TOF MS technology with membrane filter protocol for the rapid identification of microorganisms in perioperative drainage fluids of hepatobiliary pancreatic surgery.
    PLoS One. 2021;16:e0246002.
    PubMed     Abstract available


  47. MUTHULINGAM JA, Olesen SS, Hansen TM, Brock C, et al
    Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial.
    PLoS One. 2021;16:e0247653.
    PubMed     Abstract available


  48. LI T, Zhao H, Zhou H, Geng T, et al
    LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    PLoS One. 2021;16:e0247817.
    PubMed     Abstract available


  49. ZHANG C, Huang L, Xiong J, Xie L, et al
    Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.
    PLoS One. 2021;16:e0247752.
    PubMed     Abstract available


  50. CAO H, Qiang L, Chen J, Johnson KM, et al
    Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.
    PLoS One. 2021;16:e0248111.
    PubMed     Abstract available


  51. WEYHE D, Obonyo D, Uslar VN, Stricker I, et al
    Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    PLoS One. 2021;16:e0248633.
    PubMed     Abstract available


  52. CHENG YH, Chiang EI, Syu JN, Chao CY, et al
    Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
    PLoS One. 2021;16:e0247550.
    PubMed     Abstract available


  53. SUGAWARA T, Ban D, Nishino J, Watanabe S, et al
    Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
    PLoS One. 2021;16:e0249885.
    PubMed     Abstract available


  54. ZHANG W, Sakoda H, Nakazato Y, Islam MN, et al
    Neuromedin U uses Galphai2 and Galphao to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic beta cells.
    PLoS One. 2021;16:e0250232.
    PubMed     Abstract available


  55. ZHONG R, Jiang X, Peng Y, Xu H, et al
    A nomogram prediction of overall survival based on lymph node ratio, AJCC 8th staging system, and other factors for primary pancreatic cancer.
    PLoS One. 2021;16:e0249911.
    PubMed     Abstract available


  56. TARTAGLIONE S, Mancini P, Viggiani V, Chirletti P, et al
    PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
    PLoS One. 2021;16:e0251656.
    PubMed     Abstract available


  57. TIAN T, Yang Q, Zhang C, Li X, et al
    MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2021;16:e0249375.
    PubMed     Abstract available


  58. ANTWI K, Wiesner P, Merkle EM, Zech CJ, et al
    Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI.
    PLoS One. 2021;16:e0253078.
    PubMed     Abstract available


  59. KATO T, Ono H, Fujii M, Akahoshi K, et al
    Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.
    PLoS One. 2021;16:e0252917.
    PubMed     Abstract available


  60. DHAYAT SA, Tamim ANJ, Jacob M, Ebeling G, et al
    Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.
    PLoS One. 2021;16:e0252727.
    PubMed     Abstract available


  61. MALHOTRA A, Rachet B, Bonaventure A, Pereira SP, et al
    Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data.
    PLoS One. 2021;16:e0251876.
    PubMed     Abstract available


  62. RAJA A, Malik MFA, Haq F
    Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer.
    PLoS One. 2021;16:e0252344.
    PubMed     Abstract available


  63. PEISL S, Mellenthin C, Vignot L, Gonelle-Gispert C, et al
    Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature.
    PLoS One. 2021;16:e0252397.
    PubMed     Abstract available


  64. UDRISTOIU AL, Cazacu IM, Gruionu LG, Gruionu G, et al
    Real-time computer-aided diagnosis of focal pancreatic masses from endoscopic ultrasound imaging based on a hybrid convolutional and long short-term memory neural network model.
    PLoS One. 2021;16:e0251701.
    PubMed     Abstract available


  65. ULLGREN H, Fransson P, Olofsson A, Segersvard R, et al
    Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.
    PLoS One. 2021;16:e0254673.
    PubMed     Abstract available


  66. ITO G, Kawakami K, Aoyama T, Yokokawa T, et al
    Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.
    PLoS One. 2021;16:e0254726.
    PubMed     Abstract available


  67. STREICHER SA, Lim U, Park SL, Li Y, et al
    Genome-wide association study of pancreatic fat: The Multiethnic Cohort Adiposity Phenotype Study.
    PLoS One. 2021;16:e0249615.
    PubMed     Abstract available


  68. IMURA T, Inagaki A, Igarashi Y, Goto M, et al
    Optimization of dye solutions for detecting damaged pancreatic tissues during islet isolation procedures.
    PLoS One. 2021;16:e0255733.
    PubMed     Abstract available


  69. KAFITA D, Nkhoma P, Zulu M, Sinkala M, et al
    Proteogenomic analysis of pancreatic cancer subtypes.
    PLoS One. 2021;16:e0257084.
    PubMed     Abstract available


  70. BARKO PC, Williams DA
    Untargeted analysis of the serum metabolome in cats with exocrine pancreatic insufficiency.
    PLoS One. 2021;16:e0257856.
    PubMed     Abstract available


  71. GAO Y, Wang M, Guo X, Hu J, et al
    Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
    PLoS One. 2021;16:e0250539.
    PubMed     Abstract available


  72. WESTENFELDER C, Hu Z, Zhang P, Gooch A, et al
    Intraperitoneal administration of human "Neo-Islets", 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials.
    PLoS One. 2021;16:e0259043.
    PubMed     Abstract available


  73. WAKIYA T, Ishido K, Kimura N, Nagase H, et al
    Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree.
    PLoS One. 2021;16:e0259682.
    PubMed     Abstract available


  74. MAEDA K, Kuriyama N, Nakagawa Y, Ito T, et al
    Optimal management of peripancreatic fluid collection with postoperative pancreatic fistula after distal pancreatectomy: Significance of computed tomography values for predicting fluid infection.
    PLoS One. 2021;16:e0259701.
    PubMed     Abstract available


  75. XU YF, Xu X, Bhandari K, Gin A, et al
    Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.
    PLoS One. 2021;16:e0259563.
    PubMed     Abstract available


  76. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    PubMed     Abstract available


  77. LI X, Yang Q, Ye H, Li S, et al
    Comparison of pancreatic fat content measured by different methods employing MR mDixon sequence.
    PLoS One. 2021;16:e0260001.
    PubMed     Abstract available


  78. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
    Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
    PLoS One. 2021;16:e0260495.
    PubMed     Abstract available


  79. CHERUBINI A, Rusconi F, Lazzari L
    Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids.
    PLoS One. 2021;16:e0260902.
    PubMed     Abstract available


  80. WEEGH N, Zentrich E, Zechner D, Struve B, et al
    Voluntary wheel running behaviour as a tool to assess the severity in a mouse pancreatic cancer model.
    PLoS One. 2021;16:e0261662.
    PubMed     Abstract available


  81. WURTZEL JGT, Lazar S, Sikder S, Cai KQ, et al
    Platelet microRNAs inhibit primary tumor growth via broad modulation of tumor cell mRNA expression in ectopic pancreatic cancer in mice.
    PLoS One. 2021;16:e0261633.
    PubMed     Abstract available


  82. PHILLIP V, Schwab M, Haf D, Algul H, et al
    Correction: Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center.
    PLoS One. 2021;16:e0261576.
    PubMed     Abstract available


    January 2020
  83. CHOI MH, Yoon SB, Song M, Lee IS, et al
    Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography.
    PLoS One. 2020;15:e0240318.
    PubMed     Abstract available


  84. NWEKE EE, Naicker P, Aron S, Stoychev S, et al
    SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.
    PLoS One. 2020;15:e0240453.
    PubMed     Abstract available


  85. YAMAMOTO S, Nagamine Y, Miyashita T, Ito S, et al
    Perioperative and anesthetic risk factors of surgical site infection in patients undergoing pancreaticoduodenectomy: A retrospective cohort study.
    PLoS One. 2020;15:e0240490.
    PubMed     Abstract available


  86. PAVLIKOVA N, Sramek J, Jelinek M, Halada P, et al
    Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach.
    PLoS One. 2020;15:e0229430.
    PubMed     Abstract available


  87. CEBALLOS GA, Hernandez LF, Paredes D, Betancourt LR, et al
    A machine learning approach to predict pancreatic islet grafts rejection versus tolerance.
    PLoS One. 2020;15:e0241925.
    PubMed     Abstract available



  88. Correction: Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0242146.
    PubMed     Abstract available


  89. HUNG WC, Lee DY, Chiang EI, Syu JN, et al
    Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
    PLoS One. 2020;15:e0241186.
    PubMed     Abstract available


  90. THAKAR M, Hu Y, Morreale M, Lerner L, et al
    Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
    PLoS One. 2020;15:e0242974.
    PubMed     Abstract available


  91. SHEIKH M, Masoudi S, Bakhshandeh R, Moayyedkazemi A, et al
    Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
    PLoS One. 2020;15:e0243511.
    PubMed     Abstract available


  92. ROH YH, Kang BK, Song SY, Lee CM, et al
    Preoperative CT anthropometric measurements and pancreatic pathology increase risk for postoperative pancreatic fistula in patients following pancreaticoduodenectomy.
    PLoS One. 2020;15:e0243515.
    PubMed     Abstract available


  93. WOCHNER R, Clauss D, Nattenmuller J, Tjaden C, et al
    Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients.
    PLoS One. 2020;15:e0242785.
    PubMed     Abstract available


  94. DOI N, Ino Y, Angata K, Shimada K, et al
    Clinicopathological significance of core 3 O-glycan synthetic enzyme, beta1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0242851.
    PubMed     Abstract available


  95. GASTEIGER S, Primavesi F, Werkl P, Dostal L, et al
    The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective study.
    PLoS One. 2020;15:e0243510.
    PubMed     Abstract available


  96. DUORUI N, Shi B, Zhang T, Chen C, et al
    The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study.
    PLoS One. 2020;15:e0243164.
    PubMed     Abstract available


  97. MAHARAJ AD, Evans SM, Zalcberg JR, Ioannou LJ, et al
    Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework.
    PLoS One. 2020;15:e0243312.
    PubMed     Abstract available


  98. LIN ZB, Song JY, Li AC, Chen C, et al
    The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.
    PLoS One. 2020;15:e0243170.
    PubMed     Abstract available


  99. RAJPUT SA, Mirza MR, Choudhary MI
    Bergenin protects pancreatic beta cells against cytokine-induced apoptosis in INS-1E cells.
    PLoS One. 2020;15:e0241349.
    PubMed     Abstract available


  100. GRUBER ES, Jomrich G, Tamandl D, Gnant M, et al
    Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0244896.
    PubMed     Abstract available


  101. CHEN CY, Liang SH, Su YY, Chiang NJ, et al
    Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan.
    PLoS One. 2020;15:e0244487.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: